CDx Development and Commercialisation

We are uniquely placed to partner with clients throughout the entire process of CDx Development.

From the fundamental research and discovery phase, through the conduct of clinical trials and the manufacturing of test kits or lab developed tests, to the patient sample testing, Almac Diagnostics can further leverage 50 years of manufacturing and distribution experience within the Almac Group. We have the capability to produce CDx Kits for Labs  and a strong Global distribution network to support Commercialisation.

We are able to tailor our Customised CDx services to the exact requirements of our clients to ensure that their drug and companion diagnostic is competitive in the marketplace.

As disease and drug response is a complex process, we fundamentally believe that multiplex gene signatures are the key to developing the precision medicines of the future. Our experience in using complex biology can be demonstrated through our own internal R&D pipeline of assays across a range of cancer types as well as our CDx partnerships with existing pharma clients. We have extensive proven experience alongside published and validated results.

Our global, state of the art, CLIA-accredited laboratories operate both research-use-only (RUO) Assays and Clinical Trial Assays. We also have strong strategic partnerships in place with multiple platform providers, offering clients true flexibility for their CDx requirements through our flexible platform options.

We have the key organisational and logistical resources necessary to provide an end-to-end service, which can be scaled up to every major market from our clinical laboratory hubs in the USA and Europe and our partnership laboratory in Asia.

With expert supporting services teams in Project Management, Bioinformatics & Biostatistics and Quality & Regulatory Affairs we ensure that your individual project objectives are met on time, within budget and that deliver customised solutions that add real value.

Our Diagnostic experience spans:

  • Oncology
  • Immunology
  • CNS
  • Infective diseases

CDx Services Include: 

  • Design Control & Risk Management
  • Sample Sourcing
  • Assay Development & Validation
  • Assay Software Development
  • Manufacturing Capability
  • Regulatory Submissions & Registrational Trial Testing

CDx Commercialisation Options Include: 

  • Full single source laboratory (LDT-PMA) Commercialisation
  • IVD kit Commercialisation

Contact Us

Related resources

  • Almac Group Announce Companion Diagnostic Partnerships with OncoMed


    Almac Group Announce Companion Diagnostic Partnerships with OncoMed

    Learn more
  • Webinar

    Discovery, development and commercialization of Multiplex Diagnostics and Companion Diagnostics

    Learn more